Jiali Tang v. SYNUTRA INTERN., INC.

656 F.3d 242, 2011 WL 3891934
CourtCourt of Appeals for the Fourth Circuit
DecidedSeptember 6, 2011
Docket10-1487
StatusPublished
Cited by1 cases

This text of 656 F.3d 242 (Jiali Tang v. SYNUTRA INTERN., INC.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jiali Tang v. SYNUTRA INTERN., INC., 656 F.3d 242, 2011 WL 3891934 (4th Cir. 2011).

Opinion

656 F.3d 242 (2011)

JIALI TANG; Yongde Liu, in their own capacities, and ex rel. X.L., a minor; Ping Mu; Xia Chang, in their own capacities, and ex rel. Y.M., a minor; Dedong Ma; Hongxiu Lu, in their own capacities, and ex rel. L.M., a minor; Ruijie Liu; Songxia Zhu, in their own capacities, and ex rel. Y.L., a minor; Xianghong Liu; Jiaoyan Zhu, in their own capacities, and ex rel. S.L., a minor; Shuyong Yao; Fengqiong Bao, in their own capacities, and ex rel. Y.Y., a minor; Lihong Meng; Feng Zhao, in their own capacities, and ex rel. F.Z., a minor; Xiaoping Chang; Youjian Ma, in their own capacities, and ex rel. L.M., a minor; Yanmiao Cao; Zhaodi Lin, in their own capacities, and ex rel. Z.C., a minor; Hong Liu; Junjie Liu, in their own capacities, and ex rel. J.L., a minor; Yajun He; Bing Wang, in their own capacities, and ex rel. Y.W., a minor; Chunnian Wang, in his own capacity, and ex rel. Y.W., a minor; Chuang Wang; Rui Zhang, in their own capacities, and ex rel. Y.W., a minor; Qiguo Shu; Meihong Ren, in their own capacities, and ex rel. R.S., a minor; Zhaoxia Xing; Xinqiang Huang, in their own capacities, and ex rel. H.H., a minor; Wen Chen; Xiang He, in their own capacities, and ex rel. G.C., a minor; Qi Chen; Li Xue, in their own capacities, and ex rel. J.C., a minor; Xianwei Hong; Dandan Huang, in their own capacities, and ex rel. Z.H., a minor; Jinrong Zhu; Jialong Zhang, in their own capacities, and ex rel. J.Z., a minor; Xinjun Wang; Fei Li, in their own capacities, and ex rel. H.W., a minor; Xiaofei He; Ruizhong Tian, in their own capacities, and ex rel. F.T., a minor; Haibo Zhao; Xingping Jia, in their own capacities, and ex rel. C.Z., a minor; Jun Peng; Li Fang, in their own capacities, and ex rel. Q.P., a minor; Xiaoli Du; Jiang Li, in their own capacities, and ex rel. M.L., a minor; Xin Liu; Yan Zhu, in their own capacities, and ex rel. W.L., a minor; Gang Meng; Haiyan Wang, in their own capacities, and ex rel. Y.M., a minor; Zhaoxia Ji; Jiaying Niu, in their own capacities, and ex rel. Z.N., a minor; Mei Cheng; Wei Chen, in their own capacities, and ex rel. Q.C., a minor; Dongrong Li; Guoan Zhang, in their own capacities, and ex rel. B.Z., a minor; Dongyan Yu; Wei Qin, in their own capacities, and ex rel. Z.Q., a minor; Zhengya Shao; Yi Li, in their own capacities, and ex rel. H.S., a minor; Jie Gao; Chuncheng Xu, in their own capacities, and ex rel. G.X., a minor; Ming Hu; Yanling Yan, in their own capacities, and ex rel. Z.Y., a minor; Guanglu Liu; Limei Chen, in their own capacities, and ex rel. S.L., a minor; Hong Liu; Yong Fei, in their own capacities, and ex rel. C.F., a minor; Ruida Wang; Xiaoyu Li, in their own capacities, and ex rel. C.W., a minor; Erjian An; Changjing Huangfu, in their own capacities, and ex rel. Y.A., a minor; Yuan Zhang; Haitao Nan, in their own capacities, and ex rel. Y.N., a minor; Xiaofei Xie; Qiqi Xiong, in their own capacities, and ex rel. Y.X., a minor; Dongwei Zhou; Yan Zheng, in their own capacities, and ex rel. X.Z., a minor; Wei Zhao; Changyu Liu, in their own capacities, and ex rel. Y.W., a minor; Xing Wen; Yan Yue, in their own capacities, and ex rel. Y.W., a minor; Renyin Fan; Yaping Hu, in their own capacities, and ex rel. T.F., a minor; Jianhua Chen; Ning Xia, in their own capacities, and ex rel. J.C., a minor; Yuan Wen, in his own capacity, and ex rel. T.W., a minor; Xingzhi Zhu; Fangkai Yang, in their own capacities, and ex rel. Z.Y., a minor; Ping Du, in her own capacity, and ex rel. X.X., a minor; Wei Zhang, in his own capacity, and ex rel. K.Z., a minor; Lin Chen; Jie You, in their own capacities, and ex rel. J.Y., a minor; Yinghao Zhang, in his own capacity, and ex rel. Y.Z., a minor; Jinghai Yang; Jiangli Wang, in their own capacities, and ex rel. H.Y., a minor; Dianjun Wang; Junli Sun, in their own capacities, and ex rel. X.W., a minor; Yunpeng Ge; Qi Hou, in their own capacities, and ex rel. Y.G., a minor, Plaintiffs-Appellants,
v.
SYNUTRA INTERNATIONAL, INCORPORATED; Synutra, Incorporated, a/k/a American St. George Biological Technology Corporation, Defendants-Appellees.

No. 10-1487.

United States Court of Appeals, Fourth Circuit.

Argued: March 22, 2011.
Decided: September 6, 2011.

*246 ARGUED: Paul George Gaston, Law Offices of Paul G. Gaston, Washington, D.C., for Appellants. James Arden, Sidley & Austin, LLP, New York, New York, for Appellees. ON BRIEF: Paul J. Zidlicky, Sidley & Austin, LLP, Washington, D.C.; Sara J. Gourley, Sidley & Austin, LLP, Chicago, Illinois; Eamon P. Joyce, Sidley & Austin, LLP, New York, New York, for Appellees.

Before KING, GREGORY, and WYNN, Circuit Judges.

Affirmed by published opinion. Judge WYNN wrote the opinion, in which Judge KING and Judge GREGORY concurred.

OPINION

WYNN, Circuit Judge:

"A forum non conveniens dismissal must be based on the finding that, when weighed against plaintiff's choice of forum, the relevant public and private interests strongly favor a specific, adequate, and available alternative forum."[1] Plaintiffs in this case are citizens and residents of China who allege that they were injured by melamine-contaminated infant formula in China. The contaminated products were manufactured and distributed exclusively in China by, among others, Sheng Yuan Nutritional Food Company ("Sheng Yuan") — a Chinese subsidiary of Synutra International, Incorporated and Synutra, Incorporated (collectively "Synutra"). Because Synutra's principal place of business is in Maryland, Plaintiffs brought this action in Maryland seeking to recover damages for their alleged injuries that occurred in China. China, however, is an available, adequate, and more convenient forum to redress Plaintiffs' grievances; accordingly, we affirm the district court's forum non conveniens dismissal.

I.

In 2008, Chinese officials learned of widespread reports that infants in China had died or become severely ill after consuming infant formula. An investigation showed that infant formula manufactured by twenty-two Chinese companies was contaminated with melamine, a chemical which is unfit for human consumption and may afflict the kidneys.[2] One of these companies was Sheng Yuan, a subsidiary of Synutra. According to Synutra's 2009 financial statement to the United States Securities and Exchange Commission, Sheng Yuan produced, marketed and sold infant formula products in China,

[d]irectly or through its wholly owned subsidiary, Synutra, Inc[orporated], an Illinois corporation ("Synutra Illinois"), Synutra International, Inc. (collectively with its subsidiaries, "the Company" or "Synutra") owns all or majority of the equity interests of the companies in the People's Republic of China ("China" or "PRC") that are principally engaged in the production, marketing and distribution of dairy based nutritional products under the Company's own brands in *247 China. The Company is a leader in sales of infant formula products in China.
The Company produces, markets and sells nutritional products under "Sheng Yuan," or "Synutra," its master brand, and several sub-brands, including "Super," "U-Smart," and "U-Strong."

On September 16, 2008, Synutra issued a press release in China recalling the "U-Smart" line of formula products. In the press release, Synutra acknowledged that batches of its U-Smart products were found to be contaminated, and the company expressed regret for harm caused to Chinese children.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
656 F.3d 242, 2011 WL 3891934, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jiali-tang-v-synutra-intern-inc-ca4-2011.